CHRSNasdaq United States
Market cap
$196.216 M
$1.27 +0.40%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
$168.0M
#1079 by earnings
Shares outstanding
154,500,966
Latest filing cover page
P/E ratio
1.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Coherus Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.